Gilead Sciences (GILD) Net Margin (2009 - 2026)

Gilead Sciences (GILD) has reported Net Margin for 18 consecutive years, with 29.04% the latest figure, recorded in Q1 2026.

• Net Margin for Q1 2026 came in at 29.04%, up 931.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 32.16% (up 1140.0% YoY), and the FY2025 annual result was 28.9%, up 2724.0% from the prior year.
• Net Margin was 29.04% for Q1 2026 at Gilead Sciences, down from 31.9% in the prior quarter.
• Over five years, Net Margin peaked at 39.28% in Q3 2025 and troughed at 62.38% in Q1 2024.
• Average Net Margin over 5 years is 17.43%, with a median of 22.1% recorded in 2022.
• Year-over-year, Net Margin sank 7788 bps in 2024 and soared 8211 bps in 2025.
• Over 5 years, Net Margin stood at 22.1% in 2022, then fell by 10 bps to 19.9% in 2023, then increased by 18 bps to 23.54% in 2024, then surged by 35 bps to 31.9% in 2025, then dropped by 9 bps to 29.04% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 29.04% in Q1 2026, 31.9% in Q4 2025, and 39.28% in Q3 2025.